This inventor holds 2 USPTO granted patents. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1994-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994-1996
Title: Ken-ichi Nunami: Innovator in Pharmaceutical Chemistry
Introduction
Ken-ichi Nunami is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on peptides and derivatives. His expertise has led to the development of several patents that showcase his commitment to advancing medical science.
Latest Patents
Ken-ichi Nunami holds 2 patents that reflect his research and innovation. His latest patents include an indole-containing peptide and a process for preparing the same. This patent discloses an indole-containing peptide represented by a specific formula, where R can be a hydrogen atom, a lower alkyl group, or a formyl group, and X can represent oxygen or sulfur atoms, among other variations. Another significant patent involves N,3-disubstituted alaninamide derivatives, which details a dicarboxylic acid compound with various substituents and a process for its preparation.
Career Highlights
Ken-ichi Nunami is currently associated with Tanabe Seiyaku Company, Limited, where he continues to contribute to pharmaceutical research and development. His work has been instrumental in creating new compounds that have potential therapeutic applications.
Collaborations
Throughout his career, Ken-ichi has collaborated with esteemed colleagues, including Koji Yano and Kenji Omori. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Ken-ichi Nunami's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile